筛查结肠镜腺瘤切除后结直肠癌发病率与死亡率:基于波兰国家筛查项目的风险分类系统
该多中心人群队列纳入波兰国家结直肠癌筛查项目236,089例筛查结肠镜受检者,中位随访7.1年,基于腺瘤大小、异型增生级别等特征开发风险分类系统。以腺瘤≥20 mm或高级别异型增生定义高风险,可将需强化监测者从15,242例(36.5%)降至3,980例(9.5%),且不增加腺瘤患者结直肠癌风险。
要点
- 腺瘤≥20 mm或高级别异型增生与结直肠癌风险升高相关。
- 以腺瘤≥20 mm或高级别异型增生定义高风险,可减少需强化监测人数。
- 新分类不增加腺瘤患者结直肠癌风险,可优化监测结肠镜使用。
核心结论
- 基于波兰国家结直肠癌筛查项目数据开发的风险分类系统,可将需强化监测的高风险个体减少3倍以上,且不增加腺瘤患者结直肠癌风险。
研究设计与样本
- 多中心人群队列研究,纳入2000至2011年波兰国家结直肠癌筛查项目中132个中心、236,089例接受充分肠道准备和盲肠插管筛查结肠镜的个体,中位年龄56岁,37.8%为男性,中位随访7.1年。
主要发现
- 筛查切除腺瘤者中识别130例结直肠癌(46.5/100,000人年),无腺瘤者为309例(22.2/100,000人年)。
- 与无腺瘤者相比,腺瘤直径≥20 mm与结直肠癌风险升高相关(调整风险比9.25;95%CI 6.39-13.39),高级别异型增生亦相关(调整风险比3.58;95%CI 1.96-6.54)。
- 与一般人群相比,腺瘤≥20 mm者结直肠癌风险较高(标准化发病比2.07;95%CI 1.40-2.93),高级别异型增生者为0.79(95%CI 0.39-1.41),其他腺瘤特征者风险较低(标准化发病比0.35;95%CI 0.28-0.44)。
- 新高风险分类使需强化监测者从15,242例(36.5%)降至3,980例(9.5%),腺瘤患者结直肠癌风险差异为每100,000人年5.6(95%CI -10.7至22.0)。
关键数值与推荐
- 高风险分类标准:腺瘤直径≥20 mm或高级别异型增生,替代现行高风险标准(≥3个腺瘤,或任何绒毛状生长模式、高级别异型增生、或直径≥10 mm的腺瘤)。
临床怎么用
- 该风险分类系统可减少被归类为高风险并需强化监测的个体数量,从而优化监测结肠镜的资源使用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Recommendation of surveillance colonoscopy should be based on risk of colorectal cancer and death after adenoma removal. We aimed to develop a risk classification system based on colorectal cancer incidence and mortality following adenoma removal. METHODS: We performed a multicenter population-based cohort study of 236,089 individuals (median patient age, 56 years; 37.8% male) undergoing screening colonoscopies with adequate bowel cleansing and cecum intubation at 132 centers in the Polish National Colorectal Cancer Screening Program, from 2000 through 2011. Subjects were followed for a median 7.1 years and information was collected on colorectal cancer development and death. We used recursive partitioning and multivariable Cox models to identify associations between colorectal cancer risk and patient and adenoma characteristics (diameter, growth pattern, grade of dysplasia, and number of adenomas). We developed a risk classification system based on standardized incidence ratios, using data from the Polish population for comparison. The primary endpoints were colorectal cancer incidence and colorectal cancer death. RESULTS: We identified 130 colorectal cancers in individuals who had adenomas removed at screening (46.5 per 100,000 person-years) vs 309 in individuals without adenomas (22.2 per 100,000 person-years). Compared with individuals without adenomas, adenomas ≥20 mm in diameter and high-grade dysplasia were associated with increased risk of colorectal cancer (adjusted hazard ratios 9.25; 95% confidence interval [CI] 6.39-13.39, and 3.58; 95% CI 1.96-6.54, respectively). Compared with the general population, colorectal cancer risk was higher or comparable only for individuals with adenomas ≥20 mm in diameter (standardized incidence ratio [SIR] 2.07; 95% CI 1.40-2.93) or with high-grade dysplasia (SIR 0.79; 95% CI 0.39-1.41), whereas for individuals with other adenoma characteristics the risk was lower (SIR 0.35; 95% CI 0.28-0.44). We developed a high-risk classification based on adenoma size ≥20 mm or high-grade dysplasia (instead of the current high-risk classification cutoff of ≥3 adenomas or any adenoma with villous growth pattern, high-grade dysplasia, or ≥10 mm in diameter). Our classification system would reduce the number of individuals classified as high-risk and requiring intensive surveillance from 15,242 (36.5%) to 3980 (9.5%), without increasing risk of colorectal cancer in patients with adenomas (risk difference per 100,000 person-years, 5.6; 95% CI -10.7 to 22.0). CONCLUSIONS: Using data from the Polish National Colorectal Cancer Screening Program, we developed a risk classification system that would reduce the number of individuals classified as high risk and require intensive surveillance more than 3-fold, without increasing risk of colorectal cancer in patients with adenomas. This system could optimize the use of surveillance colonoscopy.
引用
- Wieszczy P, Kaminski MF, Franczyk R, et al. Colorectal Cancer Incidence and Mortality After Removal of Adenomas During Screening Colonoscopies. Gastroenterology. 2019. PMID: 31563625. doi:10.1053/j.gastro.2019.09.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。